EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Tropisetron, an Antiemetic Drug, Exerts an Anti‐Epileptic Effect Through the Activation of α7nAChRs in a Rat Model of Temporal Lobe Epilepsy

Xu Qian, Xinwen Sheng, Jiqiang Ding, Zulipiya Yiming, Jingjun Zheng, Jiagui Zhong, Tengyue Zhang, Xuemei Li, Shuqiao He, Wei Li, Mei Zhang iD

CNS Neuroscience & Therapeutics · 2024

DOI: 10.1111/cns.70086 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, 2024. Verfasst von Xu Qian und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, School of Pharmaceutical, Guangzhou Medical University and Key Laboratory of Molecular Target &Clinical Pharmacology…. Hauptthemen laut MEDLINE: alpha7 Nicotinic Acetylcholine Receptor, Anticonvulsants, Antiemetics, Disease Models, Animal. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangzhou Medical University Student Innovation Ability Enhancement Program, Jinan University Medical Union Foundation, Dongguan Social Development Technology Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Temporal lobe epilepsy (TLE), a prevalent chronic neurological disorder, affects millions of individuals and is often resistant to anti‐epileptic drugs. Increasing evidence has shown that acetylcholine (ACh) and cholinergic neurotransmission play a role in the pathophysiology of epilepsy. Tropisetron, an antiemetic drug used for chemotherapy in clinic, has displayed potential in the treatment of Alzheimer's disease, depression, and schizophrenia in animal models. However, as a partial agonist of α7 nicotinic acetylcholine receptors (α7nAChRs), whether tropisetron possesses the therapeutic potential for TLE has not yet been determined.

Methods

In this study, tropisetron was intraperitoneally injected into pilocarpine‐induced epileptic rats for 3 weeks. Alpha‐bungarotoxin (α‐bgt), a specific α7nAChR antagonist, was applied to investigate the mechanism of tropisetron. Rats were assessed for spontaneous recurrent seizures (SRS) and cognitive function using video surveillance and Morris's water maze testing. Hippocampal impairment and synaptic structure were evaluated by Nissl staining, immunohistochemistry, and Golgi staining. Additionally, the levels of glutamate, γ‐aminobutyric acid (GABA), ACh, α7nAChRs, neuroinflammatory cytokines, glucocorticoids and their receptors, as well as synapse‐associated protein (F‐actin, cofilin‐1) were quantified.

Results

The results showed that tropisetron significantly reduced SRS, improved cognitive function, alleviated hippocampal sclerosis, and concurrently suppressed synaptic remodeling and the m 6 A modification of cofilin‐1 in TLE rats. Furthermore, tropisetron lowered glutamate levels without affecting GABA levels, reduced neuroinflammation, and increased ACh levels and α7nAChR expression in the hippocampi of TLE rats. The effects of tropisetron treatment were counteracted by α‐bgt.

Conclusion

In summary, these findings indicate that tropisetron exhibits an anti‐epileptic effect and provides neuroprotection in TLE rats through the activation of α7nAChRs. The potential mechanism may involve the reduction of glutamate levels, enhancement of cholinergic transmission, and suppression of synaptic remodeling. Consequently, the present study not only highlights the potential of tropisetron as an anti‐epileptic drug but also identifies α7nAChRs as a promising therapeutic target for the treatment of TLE.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

alpha7 Nicotinic Acetylcholine ReceptorAnticonvulsantsAntiemeticsDisease Models, AnimalEpilepsy, Temporal LobePilocarpineTropisetronAnimalsMaleRatsHippocampusRats, Sprague-Dawley

Stichwörter der Autor:innen

RNA methylationTropisetroncognitive impairmenthippocampal sclerosisneuroinflammationsynaptic plasticitytemporal lobe epilepsyα7nAChRs

Substanzen

alpha7 Nicotinic Acetylcholine ReceptorAnticonvulsantsAntiemeticsPilocarpineTropisetron

Autor:innen und Institutionen

  • Department of Clinical Pharmacy, School of Pharmaceutical, Guangzhou Medical University and Key Laboratory of Molecular Target &Clinical Pharmacology, Guangzhou, China.
  • Department of Pharmacy, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
  • Department of Neurosurgery, The Six Affiliated Hospital (Dongguan Eastern Central Hospital), Jinan University, Dongguan, China.

ORCID-Profile: Mei Zhang

Förderung

  • Guangzhou Medical University Student Innovation Ability Enhancement Program
  • Jinan University Medical Union Foundation
  • Dongguan Social Development Technology Project
  • Guangdong Natural Science Foundation Project

Zitieren

APA

Qian, X., Sheng, X., Ding, J., Yiming, Z., Zheng, J., Zhong, J., Zhang, T., Li, X., He, S., Li, W., & Zhang, M. (2024). Tropisetron, an Antiemetic Drug, Exerts an Anti‐Epileptic Effect Through the Activation of α7nAChRs in a Rat Model of Temporal Lobe Epilepsy. CNS Neuroscience & Therapeutics. https://doi.org/10.1111/cns.70086

Vancouver

Qian X, Sheng X, Ding J, Yiming Z, Zheng J, Zhong J, et al. Tropisetron, an Antiemetic Drug, Exerts an Anti‐Epileptic Effect Through the Activation of α7nAChRs in a Rat Model of Temporal Lobe Epilepsy. CNS Neuroscience & Therapeutics. 2024. doi:10.1111/cns.70086

BibTeX
@article{Qian2024,
  author = {Qian, Xu and Sheng, Xinwen and Ding, Jiqiang and Yiming, Zulipiya and Zheng, Jingjun and Zhong, Jiagui and Zhang, Tengyue and Li, Xuemei and He, Shuqiao and Li, Wei and Zhang, Mei},
  title = {Tropisetron, an Antiemetic Drug, Exerts an Anti‐Epileptic Effect Through the Activation of α7nAChRs in a Rat Model of Temporal Lobe Epilepsy},
  journal = {CNS Neuroscience & Therapeutics},
  year = {2024},
  doi = {10.1111/cns.70086}
}
Kostenlos starten →